CTNM News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$267.1M

Volume

1.00M

Next Earnings

October 29th

Mkt Cap

$297.2M

Volume

1.00M

Next Earnings

October 29th

Chart Financials Earnings News About Insider Filings

BMY Reports Mixed Phase III Trial Results, Stock DownBristol Myers Squibb announced mixed Phase III results for admilparant in idiopathic pulmonary fibrosis, meeting its primary endpoint only at the 60-mg dose while failing at 120-mg, causing the stock to decline 2.6%. However, the company reported positive Phase III results for RYZ101 in advanced gastroenteropancreatic neuroendocrine tumors, demonstrating statistically significant improvement in progression-free survival. The mixed outcomes reflect uncertainty about admilparant's dose consistency despite favorable safety profiles.Zacks Investment Research · Oct 13, 2026

All You Need to Know About Contineum Therapeutics, Inc. (CTNM) Rating Upgrade to BuyContineum Therapeutics, Inc. (CTNM) has been upgraded to a Zacks Rank #2 (Buy) rating based on upward trends in earnings estimates. The upgrade reflects positivity about the company's earnings outlook and positions it in the top 20% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation.Zacks Investment Research · Oct 12, 2026

Contineum (CTNM) Q2 R&D Jumps 78%Contineum Therapeutics reported a wider Q2 2025 net loss of $0.62 per share, driven by increased R&D expenses. The company continues developing treatments for pulmonary fibrosis, multiple sclerosis, and depression, with ongoing clinical trials for PIPE-791 and PIPE-307.The Motley Fool · Aug 6, 2025

Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightThe pulmonary fibrosis market is driven by the increasing prevalence of the disease, especially idiopathic pulmonary fibrosis, among the aging population. Innovations in drug development and diagnostics, favorable reimbursement policies, and greater awareness are fueling market growth. The pipeline appears robust with over 110 active players working on 120+ pipeline drugs.GlobeNewswire Inc. · Jan 28, 2025

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of DirectorsRAPT Therapeutics, a clinical-stage biopharmaceutical company, announced the appointment of Lori Lyons-Williams as the new chair of its board of directors, succeeding William Rieflin. Lyons-Williams is an industry veteran with over 20 years of experience in the pharmaceutical and biotech sectors.GlobeNewswire Inc. · Jan 6, 2025

Wall Street Breakfast: The Week AheadThis article discusses the upcoming events in the financial world, including the Federal Reserve meeting, corporate earnings, IPOs, and investor events.Seeking Alpha · Apr 28, 2024

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionShares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. Skillsoft posted adjusted loss of $3.09 per share, versus market estimates of $3.27 per share. The company’s quarterly sales came in at $137.540 million versus expectations of $141.897 million. Skillsoft shares dipped 26.7% to $6.74 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers WiSA Technologies, Inc. (NASDAQ: WISA) jumped 85% to $3.2379 after the company announced a 5-year WiSA E licensing agreement with an HDTV/PTV brand. Palisade Bio, Inc. (NASDAQ: PALI) shares climbed 79.1% to $7.45 after the company announced the completion of analysis evaluating ex-vivo bioactivation of PALI-2108. Jaguar Health, Inc. (NASDAQ: JAGX) shares gained 67% to $0.1989 after the company signed an exclusive 5-year in-license agreement with Venture Life Group for Gelclair. Dynatronics Corporation (NASDAQ: DYNT) shares rose 44.4% to $0.5342 after dipping over 5% on Monday. IMAC Holdings, Inc. (NASDAQ: BACK) surged 40% to $4.69. Peraso Inc. (NASDAQ: PRSO) gained 38.8% to $1.75. Peraso recently announced that it received an additional $2.88 million purchase order. Macatawa Bank Corporation (NASDAQ: MCBC) rose 38.8% to $13.78 after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into a definitive merger agreement for Wintrust to acquire Macatawa in an all-stock transaction. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 29.9% to ...Benzinga · Apr 16, 2024

UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On TuesdayU.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday. Shares of UnitedHealth Group Incorporated (NYSE: UNH) rose sharply during Tuesday’s session following better-than-expected first-quarter earnings. The company reported adjusted EPS of $6.91, up from $6.26 a year ago, beating the consensus of $6.62. UnitedHealth’s revenues increased nearly $8 billion to $99.8 billion, beating the consensus of $99.3 billion, according to data from Benzinga Pro. UnitedHealth Group shares surged 6.2% to $473.20 on Tuesday. Here are some other big stocks recording losses in today’s session. Macatawa Bank Corporation (NASDAQ: MCBC) ...Benzinga · Apr 16, 2024

CTNMContineum Therapeutics, Inc. Class A Common Stock

CTNM

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any CTNM yet.

Related Tickers

Earnings

Mkt Cap

$267.1M

Volume

1.00M

Next Earnings

October 29th